Research Topics
| Karl P ClaxtonSummaryAffiliation: University of York Country: UK Publications
| Collaborators
|
Detail Information
Publications
Exploring uncertainty in cost-effectiveness analysisKarl Claxton
Centre for Health Economics, Department of Economics and NICE Decision Support Unit, University of York, Heslington, York, UK
Pharmacoeconomics 26:781-98. 2008..measures of uncertainty should be used to present the results to decision makers; and (v) should formal methods be recommended to inform the assessment of the need for evidence and the consequences of an uncertain decision for the UK NHS?..
Value based pricing for NHS drugs: an opportunity not to be missed?Karl Claxton
Centre for Health Economics, University of York, York
BMJ 336:251-4. 2008
A dynamic programming approach to the efficient design of clinical trialsK Claxton
Department of Economics, University of York, Heslington, UK
J Health Econ 20:797-822. 2001..Bayesian decision theory can provide a general methodological framework that can ensure consistency in decision making between service provision, research and development, and the design, conduct and interpretation clinical research...
Identifying research priorities: the value of information associated with repeat screening for age-related macular degenerationLaura Bojke
Centre for Health Economics, University of York, York, United Kingdom
Med Decis Making 28:33-43. 2008..This case study also illustrates the need to account for any structural uncertainties appropriately...
Discounting and decision making in the economic evaluation of health-care technologiesKarl Claxton
Centre for Health Economics, University of York, UK
Health Econ 20:2-15. 2011....
Using value of information analysis to prioritise health research: some lessons from recent UK experienceKarl P Claxton
Centre for Health Economics, University of York, York, England
Pharmacoeconomics 24:1055-68. 2006....
A rational framework for decision making by the National Institute For Clinical Excellence (NICE)Karl Claxton
Department of Economics and Related Studies, University of York, Heslington, York, UK
Lancet 360:711-5. 2002..Additionally, the analysis can be used to aid the efficient design of research. We discuss the implications of adoption of this new framework for regulatory and reimbursement decisions...
Rights, responsibilities and NICE: a rejoinder to HarrisKarl Claxton
Centre for Health Economics, University of York, Heslington, York, UK
J Med Ethics 33:462-4. 2007..Such comparisons do indeed have to be made, but this is not a consequence of the choice of any particular outcome measure, be it the QALY or anything else...
Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United KingdomClaire McKenna
Centre for Health Economics, University of York, Heslington, York, United Kingdom
Int J Technol Assess Health Care 26:175-82. 2010....
Using value of information analysis to inform publicly funded research prioritiesLaura Ginnelly
Centre for Health Economics, University of York, York, UK
Appl Health Econ Health Policy 4:37-46. 2005..The case study presented considers whether long-term, low-dose antibacterial treatment of recurrent urinary tract infections (UTIs) in children is effective and cost effective compared with short-term antibacterial therapy...
The half-life of truth: what are appropriate time horizons for research decisions?Zoe Philips
Centre for Health Economics, University of York, York, YO10 5DD corrected UK corrected
Med Decis Making 28:287-99. 2008..To evaluate alternative approaches taken to estimate the population that could benefit from research and to demonstrate that explicitly modeling future change leads to more appropriate estimates of the expected value of information (EVI)...
Pre-operative optimisation employing dopexamine or adrenaline for patients undergoing major elective surgery: a cost-effectiveness analysisElisabeth Fenwick
Centre for Health Economics, IRISS, University of York, Heslington, York, YO10 5DD, UK
Intensive Care Med 28:599-608. 2002..To compare the cost and cost-effectiveness of a policy of pre-operative optimisation of oxygen delivery (using either adrenaline or dopexamine) to reduce the risk associated with major elective surgery, in high-risk patients...
Decision analysis for resource allocation in health careSusan Griffin
Centre for Health Economics, University of York, York, UK
J Health Serv Res Policy 13:23-30. 2008..The paper concludes by describing ongoing methodological work designed to meet the challenges of undertaking decision analysis for resource allocation in health care...
Characterizing structural uncertainty in decision analytic models: a review and application of methodsLaura Bojke
Centre for Health Economics, University of York, York, UK
Value Health 12:739-49. 2009..These have been classified in a number of different ways but can be referred to collectively as structural uncertainties...
Value for money and the Quality and Outcomes Framework in primary care in the UK NHSSimon Walker
Centre for Health Economics, University of York, Heslington, York, UK
Br J Gen Pract 60:e213-20. 2010..Despite its achievements, there are concerns that the QOF may offer poor value for money...
Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisionsClaire McKenna
Centre for Health Economics, University of York, Heslington, York YO10 5DD, United Kingdom
J Health Econ 29:170-81. 2010....
Exploring the research decision space: the expected value of information for sequential research designsSusan Griffin
Centre for Health Economics, University of York, York, United Kingdom
Med Decis Making 30:155-62. 2010..To investigate the expected value of partial perfect information (EVPPI) and the research decisions it can address...
Eliciting distributions to populate decision analytic modelsLaura Bojke
Centre for Health Economics, University of York, York, UK
Value Health 13:557-64. 2010..Elicitation can be used to characterize structural uncertainty within a decision analytic model. This allows the value of acquiring further evidence to resolve these uncertainties to be established...
Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendationsHelen Weatherly
Centre for Health Economics, University of York, United Kingdom
Health Policy 93:85-92. 2009..In contrast, the economic evaluation of public health interventions raises additional methodological challenges. The paper identifies these challenges and provides suggestions for overcoming them...
OFT, VBP: QED?Karl Claxton
Department of Economics and Related Studies and Centre for Health Economics, University of York, York, UK
Health Econ 16:545-58. 2007..Whatever view is taken, the OFT report will inevitably shape the scope of future policy debates about value, guidance, price and innovation...
Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty--when is there sufficient evidence?Mark Sculpher
Centre for Health Economics, University of York, York, UK
Value Health 8:433-46. 2005....
Discounting and cost-effectiveness in NICE - stepping back to sort out a confusionKarl Claxton
NICE Task Group on Economics, UK
Health Econ 15:1-4. 2006..Nor does it reflect the debate that underpinned the guidance. We therefore welcome the opportunity to explain more completely the rationale in the minds of the principal authors of the current guidance...
Evidence synthesis, parameter correlation and probabilistic sensitivity analysisA E Ades
MRC Health Services Collaboration, Canynge Hall, England, UK
Health Econ 15:373-81. 2006..It follows that, if health technology assessments are to be based on a correct analysis of all available data, then probabilistic methods must be used both for sensitivity analysis and for estimation of expected costs and benefits...
Whither trial-based economic evaluation for health care decision making?Mark J Sculpher
Centre for Health Economics, University of York, UK
Health Econ 15:677-87. 2006..It is argued that RCT evidence, with or without economic content, should be viewed as simply one of the sources of evidence, which must be placed in a broader framework of evidence synthesis and decision analysis...
Comprehensive decision-analytic model and Bayesian value-of-information analysis: pentoxifylline in the treatment of chronic venous leg ulcersCynthia P Iglesias
Department of Health Sciences, University of York, York, UK
Pharmacoeconomics 24:465-78. 2006..To conduct a Bayesian value-of-information analysis of the cost effectiveness of pentoxifylline (vs placebo) as an adjunct to compression for venous leg ulcers...
Probabilistic analysis and computationally expensive models: Necessary and required?Susan Griffin
Center for Health Economics, University of York, York, UK
Value Health 9:244-52. 2006....
An iterative Bayesian approach to health technology assessment: application to a policy of preoperative optimization for patients undergoing major elective surgeryElisabeth Fenwick
Department of Economics and Related Studies, University of York, York, United Kingdom
Med Decis Making 26:480-96. 2006..Within the article, the framework is applied to a policy decision regarding preoperative patient management before major elective surgery, for which trial data are available...
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extraKarl Claxton
Centre for Health Economics, Department of Economics and Related Studies, University of York, UK
Health Econ 14:339-47. 2005..Finally, some of the methodological challenges posed by the need fully to characterise decision uncertainty and to inform the research agenda will be identified and discussed...
Efficiency, equity, and budgetary policies: informing decisions using mathematical programmingDavid M Epstein
Centre for Health Economics, University of York, York, UK
Med Decis Making 27:128-37. 2007..They apply this framework of analysis to a realistic and policy-relevant problem...
Dangerous omissions: the consequences of ignoring decision uncertaintySusan C Griffin
Centre for Health Economics, University of York, UK
Health Econ 20:212-24. 2011..However, decisions based solely on expected net benefit provide no such incentives, may undermine the evidence base for future clinical practice and reduce expected net health benefits for the patient population...
Dimensions of design space: a decision-theoretic approach to optimal research designStefano Conti
Centre for Health Economics, University of York, York, UK
Med Decis Making 29:643-60. 2009..The computational challenges are addressed by implementing optimization algorithms to search the ENBS surface more efficiently over such large dimensions...
Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical ExcellenceAnthony Culyer
Department of Economics and Related Studies, University of York, York, UK
J Health Serv Res Policy 12:56-8. 2007....
When is evidence sufficient?Karl Claxton
University of York, United Kingdom
Health Aff (Millwood) 24:93-101. 2005..Value-of-information analysis, a related methodology, helps to determine whether it is worthwhile to collect additional information as well as the type of research that would be most helpful...
